Neurotherapeutics Symposium 2022: Integrating Equity within Translational Research
Neurotherapeutics Symposium 2022: Integrating Equity within Translational Research
批准号:
10391768
负责人:
Karlo J. Lizarraga
金额:
$2.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-12-15 至 2022-11-30
关键词:
AddressAdvisory CommitteesAwardClimactericDevelopmentDisabled PersonsDissemination and ImplementationFutureGoalsHealthKnowledgeMeasuresMedicineMentorsMinority GroupsMissionMultiple SclerosisNeurologicNeurologyOutcomeParkinson DiseaseParticipantPatientsPhasePrizePublic HealthResearchResearch PersonnelStrokeSurveysTherapy trialTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of Healthcareercostcurative treatmentsdesignhealth equityhealth inequalitiesimprovedlecturesmeetingsmultiple sclerosis patientpostersrecruitsymposiumtherapy developmentvirtual
中文摘要
项目总结
对于致残和致命的神经系统疾病,改变生活和治疗的方法是昂贵的和
来自代表不足的少数族裔(URM)人群的患者通常无法接触到。在运输期间-
神经学的全国性研究,这种难以接近的现象大多始于治疗的发展。
并在实施和传播阶段不断发展壮大。因此,有一种
迫切需要对神经科工作人员进行广泛教育,让他们了解整合股权的重要性
专注于神经学的翻译研究,最终目标是加速翻译-
将神经治疗的进步转化为改善所有患者的健康结果。作为
首次致力于解决这一问题的虚拟会议--“神经治疗学研讨会”
2022年:将公平纳入翻译研究“,将实现以下目标:1)非集中化--
传授有关现有不平等现象的知识,并持续努力在翻译中整合公平-
神经学的传统研究,2)促进正在进行的和
研讨会参与者未来的翻译研究努力,以及3)评估以下方面的程度
与会者了解现有的不平等现象和正在进行的将公平纳入跨国界的努力
神经学方面的全国性研究有所增加。在网上注册期间,一项关于
10道多项选择题将评估会前对1)存在的不平等现象的了解-
ING神经学方面的翻译研究和2)持续努力将公平纳入翻译-
神经学的传统研究。已登记的参与者,特别是实习生和职业生涯初期的投资人-
老虎,将被鼓励提交摘要来展示他们的研究。摘要将包括
《股权焦点》,强调这一议题对大会的重要性。在症状出现的时候-
,该领域的专家将发表10场虚拟演讲,并将参加四个小组讨论,使用
以中风、多发性硬化症和帕金森氏症为例,说明会议的主题-
费伦斯。三次辅导小组会议和一次虚拟海报演示会议将促进
讨论、发展和扩大所提交摘要中所述的“股权重点”。
研讨会结束六个月后,同样的电子调查将衡量与会议前相比的变化。
弗伦斯知识。本次大会的预期成果是,多达150名与会者将
增加了他们的知识,并在他们的当前和未来将重点放在了股票上
神经学方面的转译研究努力。
英文摘要
PROJECT SUMMARY
Life-changing and curative therapies for disabling and fatal neurological conditions are costly and
often inaccessible for patients from underrepresented minority (URM) populations. During trans-
lational research in neurology, much of this inaccessibility begins at the therapy development
phase and grows through the implementation and dissemination phases. There is, therefore, a
critical need to widely educate the neurology workforce on the importance of integrating an equity
focus within translational research in neurology, with the ultimate goal of accelerating the transla-
tion of advances in neurological therapy into improved health outcomes for all patients. As the
first virtual conference dedicated to address this problem, the “Neurotherapeutics Symposium
2022: Integrating Equity within Translational Research”, will achieve the following aims: 1) dis-
seminate knowledge on existing inequities and ongoing efforts to integrate equity within transla-
tional research in neurology, 2) facilitate the integration of an equity focus within ongoing and
future translational research efforts of symposium participants, and 3) assess the extent to which
participants knowledge on existing inequities and ongoing efforts to integrate equity within trans-
lational research in neurology has increased. During online registration, an electronic survey of
10 multiple-choice questions will assess pre-conference knowledge on 1) existing inequities dur-
ing translational research in neurology and 2) ongoing efforts to integrate equity within transla-
tional research in neurology. Registered participants, particularly trainees and early-career inves-
tigators, will be encouraged to submit abstracts to present their research. Abstracts will include
an “equity focus” to emphasize the importance of this topic for the conference. During the sympo-
sium, experts in the field will deliver 10 virtual lectures and will participate in four panels using
stroke, multiple sclerosis and Parkinson’s disease as examples to illustrate the topics of the con-
ference. Three mentoring group sessions and a virtual poster presentation session will facilitate
discussion, development and expansion of the “equity focus” described in submitted abstracts.
Six months after the symposium, the same electronic survey will measure change from pre-con-
ference knowledge. The expected outcomes of this conference is that up to 150 participants will
have increased their knowledge and integrated an equity focus within their ongoing and future
translational research efforts in neurology.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金